Logo Image
News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Nadia K. Waheed, MD, MPH

Advertisement

Articles by Nadia K. Waheed, MD, MPH

Nadia Waheed, MD, MPH: Transforming retinal disease imaging and clinical trials

ByNadia K. Waheed, MD, MPH,Hattie Hayes,Martin David Harp,Sydney M Crago
October 9th 2025

Ultra-high-resolution OCT advances retinal imaging, enabling detailed visualization of disease progression and potential therapeutic effects in eye conditions.

Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial Design

ByPeter K. Kaiser, MD,Jeffrey Heier, MD,Nadia K. Waheed, MD, MPH
July 28th 2025

Parafoveal retinal vessel density assessment by OCTA in healthy eyes

ByMalvika Arya, BS,A. Yasin Alibhai, MD,Carl B. Rebhun, BA,Xuejing Chen, MD,Elias Reichel, MD ,Caroline R. Baumal, MD ,Andre J. Witkin, MD ,Jay S. Duker, MD ,Nadia K. Waheed, MD, MPH
July 25th 2018

Study aims to identify methodology for least amount of variation, greatest test-retest reliability

Advertisement

Latest Updated Articles

  • Nadia Waheed, MD, MPH: Transforming retinal disease imaging and clinical trials
    Nadia Waheed, MD, MPH: Transforming retinal disease imaging and clinical trials

    October 9th 2025

  • Parafoveal retinal vessel density assessment by OCTA in healthy eyes
    Parafoveal retinal vessel density assessment by OCTA in healthy eyes

    July 25th 2018



Advertisement
Advertisement

Trending on Modern Retina

1

CTS 2026: OTX-TKI demonstrates superiority over aflibercept in wet AMD—what the SOL-1 data mean for retina practice

2

Ranluspec FDA approval: Cyrus Karkaria, PhD, on biosimilar access, prefilled syringes, and long-term switching confidence

3

StemSight gains patent for off-the-shelf limbal stem cell platform patent milestone for STE-101

4

Phase 3 NORTHSTAR trial launches for gildeuretinol in stargardt disease

5

Geographic atrophy: When lesion borders cannot be graded

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us